Our Services
Cerba Lancet Africa
Tests in the Catalogue
Number of Sites
Average Monthly Number of Tests
Average Monthly Number of Patients
Latest News

Cerba Lancet Kenya Partners with Fashion on the Road and Oxygene Marketing & Communications to Champion Cervical Cancer Awareness in Kenya
2025 Newsletters | 2025-10-22
September 18, 2025 - In a powerful effort to raise awareness and promote early screening for cervical cancer in Kenya, Cerba Lancet Kenya, Fashion on the Road, and Oxygene Marketing & Communications, have joined forces to spotlight the importance of early detection, regular screening, and accessible health services for cervical cancer, which is the second most common cancer among Kenyan women after breast cancer.
L’immunohistochimie, un pilier du diagnostic du cancer du sein
2025 Newsletters | 2025-10-20
Le diagnostic du cancer du sein repose aujourd’hui sur des techniques de plus en plus fines et fiables. Parmi elles, l’immunohistochimie (IHC) occupe une place centrale. Cette méthode permet d’analyser le comportement biologique d’une tumeur et d’en déterminer les caractéristiques essentielles pour orienter le traitement.
Understanding Breast Cancer
2025 Newsletters | 2025-10-01
Breast cancer is a malignant tumour that develops in the breast and can spread to other parts of the body.
Other names for breast cancer include breast carcinoma, mammary carcinoma, or cancer, or the scientific
name of the specific cancer, for example, duct carcinoma.
BRCA Testing for Hereditary Breast and /or Ovarian Cancer
2025 Newsletters | 2025-10-01
Hereditary breast and ovarian cancer syndrome is a type of familial cancer, and is linked to mutations in
two genes called BRCA1 and BRCA2. BRCA1 and BRCA2 are known as tumour suppressor genes – they
prevent cells from growing too rapidly or in an uncontrolled way. Thousands of mutations have been
found in these genes, but only some have been linked to an increased risk of cancer.